These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15177542)

  • 1. Treatment of inflammatory bowel disease with antibiotics.
    Isaacs KL; Sartor RB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):335-45, x. PubMed ID: 15177542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibiotics in the management of inflammatory bowel disease: a review.
    Rubin DT; Kornblunth A
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():S10-5. PubMed ID: 17713454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
    Cummings JH; Kong SC
    Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease.
    Epple HJ
    Dig Dis; 2009; 27(4):555-9. PubMed ID: 19897974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of inflammatory bowel disease].
    Jojić N
    Acta Chir Iugosl; 2000; 47(1-2):51-5. PubMed ID: 10953366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibiotics in the treatment of inflammatory bowel disease.
    Perencevich M; Burakoff R
    Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobials in the management of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Tambasco R; Campieri M
    Digestion; 2006; 73 Suppl 1():77-85. PubMed ID: 16498255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
    Ohkusa T; Sato N
    J Gastroenterol Hepatol; 2005 Mar; 20(3):340-51. PubMed ID: 15740475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious gastroenteritis in relapses of inflammatory bowel disease. Therapeutic implications].
    Baliellas C; Xiol X; Barenys M; Saavedra J; Casanovas T; Iborra M; Sesé E
    Rev Esp Enferm Dig; 1996 Jun; 88(6):419-22. PubMed ID: 8755323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?
    Reuter BK; Pizarro TT
    Eur J Immunol; 2004 Sep; 34(9):2347-55. PubMed ID: 15307167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.